PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11865873

A case for permitting altruistic surrogacy.

B M Baker
View original source ↗Export metadata ↓

Abstract

Canada's Royal Commission on New Reproductive Technologies rejects all forms of surrogacy arrangement under the rubric of objecting to commercial surrogacy. Noncommercial surrogacy arrangements, however, can be defended against the commission's objections. They can be viewed as cases of giving a benefit or service to another in a way that expresses benevolence, and establishes a relationship between surrogates and prospective 'social' parents that allows mutual understanding and reciprocal personal interaction between them.

Explore related subjects

Advisory CommitteesAltruismCanadaChildCoercionCommodificationEmpathyEthicsFamilyFamily RelationsFemaleFeminismGift GivingGovernment RegulationHumansInfertilityInformed ConsentMaleMotivationPregnancyPublic PolicyReproductionRisk AssessmentSelf ConceptSocial DominanceStereotypingGestational CarriersAnalytical ApproachGenetics and ReproductionRoyal Commission on New Reproductive Technologies (Canada)Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B M Baker. 1996. A case for permitting altruistic surrogacy.. https://pubmed.ncbi.nlm.nih.gov/11865873/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗